GLP-3(RT)

GLP-3(RT) is a single-peptide research compound that acts as a triple agonist of the GIP, GLP-1, and glucagon receptors—three class B G-protein-coupled receptors. It is studied for its receptor-level pharmacology: combined incretin-receptor agonism driving glucose-dependent insulinotropic signaling, balanced against glucagon-receptor activation associated with hepatic energy and lipid-oxidation signaling. This ‘triple-G’ mechanism positions GLP-3(RT) at the frontier of multi-receptor metabolic research.